Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 248

Results For "PLI"

2778 News Found

HCL Tech and Innovaccer collaborate to scale up digital health transformation
Digitisation | October 20, 2021

HCL Tech and Innovaccer collaborate to scale up digital health transformation

By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance


U.S. FDA authorises new saliva sample collection for Covid-19
Medical Device | October 19, 2021

U.S. FDA authorises new saliva sample collection for Covid-19

The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day


Alcon announces launch of AcrySof IQ Vivity in India,
Medical Device | October 19, 2021

Alcon announces launch of AcrySof IQ Vivity in India,

It is the first presbyopia-correcting lens implant for cataract surgery


Dr Reddy’s Labs announces U.S. FDA approval for Lenalidomide capsules
Drug Approval | October 19, 2021

Dr Reddy’s Labs announces U.S. FDA approval for Lenalidomide capsules

The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg


MSN Labs launches drug for diabetes management
Drug Approval | October 19, 2021

MSN Labs launches drug for diabetes management

The company claims that its Empagliflozin tablets are the most affordable in India


Resilience and Harvard announce five-year R&D alliance
News | October 18, 2021

Resilience and Harvard announce five-year R&D alliance

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders


Granules gets ANDA approval for Dofetilide capsules
Drug Approval | October 18, 2021

Granules gets ANDA approval for Dofetilide capsules

The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm


Exelixis in-licenses second anti-cancer compound from Aurigene
Biotech | October 15, 2021

Exelixis in-licenses second anti-cancer compound from Aurigene

U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma


PCI Pharma Services acquires LSNE for its CDMO business
News | October 13, 2021

PCI Pharma Services acquires LSNE for its CDMO business

Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle


American Diabetes Association acknowledges Breath Well-being diabetes reversal programme
News | October 13, 2021

American Diabetes Association acknowledges Breath Well-being diabetes reversal programme

BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes